Enable your JavaScript to use Numstock


Numstock » AGLE

AGLE Stock Analysis

The latest metrics for Aeglea BioTherapeutics, Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -3.41
Price / Book Value Ratio < 1.5 2.84
Price / Sales Ratio < 2.0 0.0
PEG Ratio < 1.0 0.0
EV / EBITDA Ratio < 8.0 -1.96
Price / FCF Ratio Last Year < 15.0 -3.58
Price / FCF Ratio Last Quarter < 15.0 -11.59
Price / TBV Ratio Last Year < 0.7 2.44
Price / TBV Ratio Last Quarter < 0.7 3.24
Price / NCAV Ratio Last Year < 0.7 2.48
Price / NCAV Ratio Last Quarter < 0.7 3.57

Efficiency

Metric Target Value
ROE Last Year > 25.0% -75.32
ROE Last Quarter > 25.0% -24.05
ROA Last Year > 15.0% -57.05
ROA Last Quarter > 15.0% -21.55
ROTA Last Year > 20.0% -45.42
ROTA Last Quarter > 20.0% -22.12
ROIC Last Year > 20.0% -79.87
ROIC Last Quarter > 20.0% -31.67
ROCE Last Year > 20.0% -67.35
ROCE Last Quarter > 20.0% -24.65
Inventory Turnover Last Year > 4.0 0.0
Inventory Turnover Last Quarter > 4.0 0.0
Pre-tax Margin Last Year > 20.0% -1444
Pre-tax Margin Last Quarter > 20.0% 0.0
Accounts Payable Turnover Last Year > 3.0 55.38
Accounts Payable Turnover Last Quarter > 3.0 7.34
Accounts Receivable Turnover Last Year > 5.0 122.4
Accounts Receivable Turnover Last Quarter > 5.0 59.46

Health

Metric Target Value
Current Ratio Last Year > 1.5 7.49
Current Ratio Last Quarter > 1.5 9.05
Quick Ratio Last Year > 1.5 7.49
Quick Ratio Last Quarter > 1.5 9.05
Flow Ratio Last Year < 1.25 5.29
Flow Ratio Last Quarter < 1.25 6.65
Debt / Equity Ratio Last Year < 0.5 0.0
Debt / Equity Ratio Last Quarter < 0.5 0.0
Debt / EBITDA Ratio Last Year < 4.0 0.0
Debt / EBITDA Ratio Last Quarter < 4.0 0.0
Debt / NCAV Ratio Last Year < 2.0 0.0
Debt / NCAV Ratio Last Quarter < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.0
Interest Coverage Ratio Ratio Last Year > 8.0 0.0
Interest Coverage Ratio Last Quarter > 8.0 0.0
FCF / Sales Ratio Last Year > 8.0% -838.9
FCF / Sales Ratio Last Quarter > 8.0% 0.0

Growth

Metric Target Value
Earnings Yield > 12% -29.36
Ebit Yield Last Year > 12% -21.16
Ebit Yield Last Quarter > 12% -9.94
FCF Yield Last Year > 10% -14.37
FCF Yield Last Quarter > 10% -7.65
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 0.67
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.23

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -1.69
Altman Z-score Last Quarter ≥ 3.5 -0.62